Clinical Trials Browser

Phase 2 × Terminated × 4,17 beta-dihydroxy-4-androstene-3-one × Clear all

NCT02067741 2023-06-27

CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer

Phase 2 Terminated

Breast Neoplasms